Synthesis of cytotoxic 4-sulfonyl-, 4-sulfonylthio-and 4- sulfothioazetidinones-2

Chemistry of Heterocyclic Compounds

Volumn 40, Issue 6, 2004, Pages 816-822

  Veinberg, G ^a   Vorona, M ^a   Musel, D ^a   Bokaldere, R ^a   Shestakova, I ^a   Kanepe, I ^a   Lukevics, E ^a  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

2 4 sulfonyl 2 oxoazetidinyl 1 2 (isopropyliden)acetic acid esters; 2 4 sulfonylthio 2 oxoazetidinyl 1 and 2 4 sulfothio 2 oxoazetidinyl 1 2 (isopropenyl)acetic acid esters; cytotoxic activity

Indexed keywords

4 SULFONYLAZETIDINONE; 4 SULFONYLTHIOAZETIDINONE; 4 SULFOTHIOAZETIDINONE; 6BETA (TERT BUTOXYCARBONYL)AMINOPENICILLANIC ACID; ANTINEOPLASTIC AGENT; AZETIDINONE DERIVATIVE; BENZHYDRYL 2 (4 BENZYLSULFONYL 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZHYDRYL 2 (4 METHYLSULFONYL 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZHYDRYL 2 (4 METHYLSULFONYLTHIO 2 OXOAZETIDINYL) 1 (2 ISOPROPENYL)ACETATE; BENZHYDRYL 2 [4 (2 NAPHTHYL)SULFONYLTHIO 2 OXOAZETIDINYL] 1 (2 ISOPROPENYL)ACETATE; BENZHYDRYL 2 [4 (4 METHOXYCARBONYLAMINOPHENYL)SULFONYLTHIO 2 OXOAZETIDINYL] 1 (2 ISOPROPENYL)ACETATE; BENZHYDRYL 2 [4 (4 TOLYL)SULFONYLTHIO 2 OXOAZETIDINYL] 1 (2 ISOPROPENYL)ACETATE; BENZYL 2 (3 AMINO 4 METHYLSULFONYL 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZYL 2 (3 CHLORO 4 METHYLSULFONYL 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZYL 2 (4 BENZYLSULFONYL 3 CHLORO 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZYL 2 (4 PROP 1 ENYLSULFONYL 3 CHLORO 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BENZYL 2 (4 PROP 2 ENYLSULFONYL 3 CHLORO 2 OXOAZETIDINYL) 1 (2 ISOPROPYLIDEN)ACETATE; BETA LACTAM; CYTOTOXIC AGENT; HALIDE; PENICILLIN DERIVATIVE; SODIUM 2 (4 SULFOTHIO 3 CHLORO 2 OXAZETIDINYL) 1 (2 ISOPROPENYL)ACETATE; SODIUM 2 (SULFOTHIO 2 OXOAZETIDINYL) 1 (2 ISOPROPENYL)ACETATE; SULFIDE; SULFUR DERIVATIVE; UNCLASSIFIED DRUG;

CANCER CELL; CHEMICAL MODIFICATION; CHEMICAL REACTION KINETICS; CONFERENCE PAPER; CYTOTOXICITY; DRUG SYNTHESIS; IN VITRO STUDY; SUBSTITUTION REACTION;

EID: 4544230991     PISSN: 00093122     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:COHC.0000040782.42204.4f     Document Type: Conference Paper

References (9)

1. G. Veinberg, R. Bokaldere, K. Dikovskaya. M. Vorona, D. Musel, H. Kazhoka, I. Turovsky, I. Shestakova, I. Kanepe, I. Domrachova, and E. Lukevics, Chem. Heterocycl. Comp., 34, 1266 (1998).
2. G. Veinberg, R. Bokaldere, K. Dikovskaya. M. Vorona, I. Kanepe, I. Shestakova, and E. Lukevics, Khim. Geterotsikl. Soed., 680 (2003).
3. C. M. Pant and R. J. Stoodley, J. Chem. Soc., Perkin Trans. 1, 1366 (1978).
4. I. Lukic, Org. Prep. Proc. Int. Briefs, 31, 352 (1999).
5. K. Prasad, G. Schulz, H. Hamberger, and P. Stutz, Heterocycles, 19, 291 (1982).
6. S. Torii, H. Tanaka, M. Sasaoka, S. Nagao, S. Uto, S. Hayase, and T. Shiroi, Ger. Offen. DE 3443225; Chem. Abstr., 103, 123265 (1985).
7. Fujisawa Pharmaceutical Co. Ltd., Jpn. Pat., 57 57474; Chem. Abstr., 98, 197890 (1983).
8. J. F. Kerwin Jr., F. R. J. Lancaster Jr., and P. L. Feldman, J. Med. Chem., 38, 4343 (1995).
9. G. A. Veinberg, I. Shestakova, N. Grigan, D. Musel, I. Kanepe, I. Domrachova, V. Grigoryeva, O. Zharkova, I. Turovskis, I. Kalvinsh, A. Strakovs, and E. Lukevics, Eur. J. Med. Chem., 33, 755 (1998).